Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG effects on lymphocyte subsets in severe aplastic anemia
NL-OMON42742Withdrawn
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2016
- Modality
- Small Molecules, Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of antithymocyte globulin rabbit and cyclosporine in aplastic anemia and acquired aplastic anemia (AAA), sponsored by Leiden University Medical Center. Primary endpoint: Number and phenotype of circulating lymphocytes before, during and after treatment with ATG. Planned start Jan 2016; status: withdrawn.
02
Drugs
antithymocyte globulin rabbitcyclosporine
03
Conditions
aplastic anemiaacquired aplastic anemia (AAA)
Beyond the preview
Go deeper on NL-OMON42742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42742.